<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Funct Morphol Kinesiol</journal-id><journal-id journal-id-type="iso-abbrev">J Funct Morphol Kinesiol</journal-id><journal-id journal-id-type="publisher-id">jfmk</journal-id><journal-title-group><journal-title>Journal of Functional Morphology and Kinesiology</journal-title></journal-title-group><issn pub-type="epub">2411-5142</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407445</article-id><article-id pub-id-type="pmc">PMC12101270</article-id>
<article-id pub-id-type="doi">10.3390/jfmk10020161</article-id><article-id pub-id-type="publisher-id">jfmk-10-00161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>May Patients with Chronic Stroke Benefit from Robotic Gait Training with an End-Effector? A Case-Control Study</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3284-9741</contrib-id><name><surname>Bonanno</surname><given-names>Mirjam</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref><xref rid="fn1-jfmk-10-00161" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1688-2151</contrib-id><name><surname>De Pasquale</surname><given-names>Paolo</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref><xref rid="c1-jfmk-10-00161" ref-type="corresp">*</xref><xref rid="fn1-jfmk-10-00161" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Lombardo Facciale</surname><given-names>Antonino</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Dauccio</surname><given-names>Biagio</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9503-4366</contrib-id><name><surname>De Luca</surname><given-names>Rosaria</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Quartarone</surname><given-names>Angelo</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref><xref rid="af2-jfmk-10-00161" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8566-3166</contrib-id><name><surname>Calabr&#x000f2;</surname><given-names>Rocco Salvatore</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-jfmk-10-00161" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Sakellari</surname><given-names>Vasiliki</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Gioftsos</surname><given-names>George</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jfmk-10-00161"><label>1</label>IRCCS Centro Neurolesi Bonino-Pulejo, 98124 Messina, Italy; <email>mirjam.bonanno@irccsme.it</email> (M.B.); <email>antonino.lombardo@irccsme.it</email> (A.L.F.); <email>biagio.dauccio@irccsme.it</email> (B.D.); <email>rosaria.deluca@irccsme.it</email> (R.D.L.); <email>angelo.quartarone@irccsme.it</email> (A.Q.); <email>roccos.calabro@irccsme.it</email> (R.S.C.)</aff><aff id="af2-jfmk-10-00161"><label>2</label>Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy</aff><author-notes><corresp id="c1-jfmk-10-00161"><label>*</label>Correspondence: <email>paolo.depasquale@irccsme.it</email></corresp><fn id="fn1-jfmk-10-00161"><label>&#x02020;</label><p>These authors contributed equally to the work.</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>161</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2025</year></date><date date-type="rev-recd"><day>02</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background</bold>: Gait and balance alterations in post-stroke patients are one of the most disabling symptoms that can persist in chronic stages of the disease. In this context, rehabilitation has the fundamental role of promoting functional recovery, mitigating gait and balance deficits, and preventing falling risk. Robotic end-effector devices, like the G-EO system (e.g., G-EO system, Reha Technology, Olten, Switzerland), can be a useful device to promote gait recovery in patients with chronic stroke. <bold>Materials and Methods:</bold> Twelve chronic stroke patients were enrolled and evaluated at baseline (T0) and at post-treatment (T1). These patients received forty sessions of robotic gait training (RGT) with the G-EO system (experimental group, EG), for eight weeks consecutively, in addition to standard rehabilitation therapy. The data of these subjects were compared with those coming from a sample of twelve individuals (control group, CG) matched for clinical and demographic features who underwent the same amount of conventional gait training (CGT), in addition to standard rehabilitation therapy. <bold>Results:</bold> All patients completed the trial, and none reported any side effects either during or following the training. The EG showed significant improvements in balance (<italic toggle="yes">p</italic> = 0.012) and gait (<italic toggle="yes">p</italic> = 0.004) functions measured with the Tinetti Scale (TS) after RGT. Both groups (EG and CG) showed significant improvement in functional independence (FIM, <italic toggle="yes">p</italic> &#x0003c; 0.001). The Fugl-Meyer Assessment&#x02014;Lower Extremity (FMA-LE) showed significant improvements in motor function (<italic toggle="yes">p</italic> = 0.001, <italic toggle="yes">p</italic> = 0.031) and passive range of motion (<italic toggle="yes">p</italic> = 0.031) in EG. In EG, gait and balance improvements were influenced by session, age, gender, time since injury (TSI), cadence, and velocity (<italic toggle="yes">p</italic> &#x0003c; 0.05), while CG showed fewer significant effects, mainly for age, TSI, and session. EG showed significantly greater improvements than CG in balance (<italic toggle="yes">p</italic> = 0.003) and gait (<italic toggle="yes">p</italic> = 0.05) based on the TS. <bold>Conclusions:</bold> RGT with end-effectors, like the G-EO system, can be a valuable complementary treatment in neurorehabilitation, even for chronic stroke patients. Our findings suggest that RGT may improve gait, balance, and lower limb motor functions, enhancing motor control and coordination.</p></abstract><kwd-group><kwd>robotic gait training</kwd><kwd>neurorehabilitation</kwd><kwd>gait and balance</kwd><kwd>end-effector</kwd><kwd>lower limb</kwd><kwd>chronic stroke</kwd></kwd-group><funding-group><award-group><funding-source>Ministry of Health, Italy</funding-source></award-group><funding-statement>This research was supported by Current Research Funds 2025, Ministry of Health, Italy.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-jfmk-10-00161"><title>1. Introduction</title><p>Gait and balance alterations in post-stroke patients are some of the most disabling symptoms that can persist in the chronic stages of the disease [<xref rid="B1-jfmk-10-00161" ref-type="bibr">1</xref>,<xref rid="B2-jfmk-10-00161" ref-type="bibr">2</xref>,<xref rid="B3-jfmk-10-00161" ref-type="bibr">3</xref>]. Generally, post-stroke patients can manifest abnormal gait patterns characterized by temporal and spatial asymmetry between steps [<xref rid="B4-jfmk-10-00161" ref-type="bibr">4</xref>]. This asymmetry during gait could result in postural instability and a lack of coordination to both self-induced and external balance perturbations [<xref rid="B5-jfmk-10-00161" ref-type="bibr">5</xref>]. According to some authors [<xref rid="B2-jfmk-10-00161" ref-type="bibr">2</xref>,<xref rid="B3-jfmk-10-00161" ref-type="bibr">3</xref>], stroke-related gait deficits, leading to fall risk, comprise reduced propulsion at push-off, decreased hip and knee flexion during the swing phase, and reduced stability during the stance phase. All these gait features can represent the cause of falling in this patient population, leading to further medical complications. It is noteworthy that post-stroke patients represent a heterogeneous group due to variations in the location and extent of brain damage. As a result, they may exhibit diverse step length patterns in both the paretic and non-paretic limbs. These variations are often linked to compensatory adjustments involving the pelvis and the unaffected side of the body [<xref rid="B6-jfmk-10-00161" ref-type="bibr">6</xref>].</p><p>In this context, physiotherapy is fundamental to promoting functional recovery, mitigating gait and balance deficits, and preventing fall risk [<xref rid="B7-jfmk-10-00161" ref-type="bibr">7</xref>,<xref rid="B8-jfmk-10-00161" ref-type="bibr">8</xref>]. Both conventional rehabilitation approaches and innovative technologies have proved their effectiveness in post-stroke patients [<xref rid="B7-jfmk-10-00161" ref-type="bibr">7</xref>,<xref rid="B8-jfmk-10-00161" ref-type="bibr">8</xref>]. However, limited evidence exists in the context of chronic stroke patients [<xref rid="B9-jfmk-10-00161" ref-type="bibr">9</xref>,<xref rid="B10-jfmk-10-00161" ref-type="bibr">10</xref>], in which it is commonly thought that neuroplastic processes and the subsequent functional recovery are already exhausted.</p><p>Among the innovative approaches, robotic rehabilitation devices play a crucial role, enabling intensive, repetitive, and task-oriented training to stimulate neuroplastic processes, even in chronic stages [<xref rid="B10-jfmk-10-00161" ref-type="bibr">10</xref>,<xref rid="B11-jfmk-10-00161" ref-type="bibr">11</xref>]. Robotic devices are generally categorized into two main types based on their biomechanical interaction with patients: exoskeletons and end-effectors [<xref rid="B8-jfmk-10-00161" ref-type="bibr">8</xref>].</p><p>End-effectors, such as the G-EO system (Reha Technology, Olten, Switzerland), are equipped with a single distal control, providing a propulsive motion of the legs thanks to two footplates that replicate the motion of stance and swing phases during gait training [<xref rid="B12-jfmk-10-00161" ref-type="bibr">12</xref>]. This design contrasts with exoskeletons, wearable powered orthoses that guide joint movements more proximally (e.g., Ekso-GT, Indego, or Lokomat) [<xref rid="B12-jfmk-10-00161" ref-type="bibr">12</xref>,<xref rid="B13-jfmk-10-00161" ref-type="bibr">13</xref>]. While exoskeletons, especially the Lokomat, have demonstrated effectiveness in promoting functional recovery and brain connectivity changes in chronic post-stroke patients [<xref rid="B10-jfmk-10-00161" ref-type="bibr">10</xref>], evidence supporting the efficacy of end-effector devices, particularly the G-EO system, remains limited [<xref rid="B14-jfmk-10-00161" ref-type="bibr">14</xref>] in this population. Most available studies have focused on acute and subacute stages [<xref rid="B15-jfmk-10-00161" ref-type="bibr">15</xref>,<xref rid="B16-jfmk-10-00161" ref-type="bibr">16</xref>,<xref rid="B17-jfmk-10-00161" ref-type="bibr">17</xref>], leaving a gap in the literature regarding their use in chronic stroke.</p><p>Given this background, this study aims to evaluate the effects of robotic end-effector gait rehabilitation training (RGT) in patients with chronic stroke and compare the functional outcomes with a matched control group receiving conventional gait training (CGT). To achieve this, we clinically assessed both rehabilitation approaches at baseline and post-treatment. A linear mixed effects (LME) model was employed to analyze the influence of demographic, clinical, and rehabilitation variables on the outcomes in both groups.</p></sec><sec id="sec2-jfmk-10-00161"><title>2. Materials and Methods</title><p>Twelve chronic post-stroke patients, attending the Robotic and Behavioral Neurorehabilitation Unit of the IRCCS Centro Neurolesi &#x0201c;Bonino-Pulejo&#x0201d; between January 2021 and August 2021, were evaluated for inclusion in this study.</p><p>Inclusion criteria were (i) hemiplegia/hemiparesis due to a first-ever stroke; (ii) at least one year after stroke; (iii) supervision-dependent ambulation (Functional Ambulation Classification&#x02014;FAC &#x02265; 3); (iv) patients aged between 18 and 75 years. Patients were excluded if they presented the following criteria: (i) age &#x0003e; 75 years; (ii) diagnosis of concurrent psychiatric conditions or other significant medical comorbidities that could interfere with the RGT; (iii) presence of deficits (e.g., cognitive, visual, or auditory) that could limit the comprehension and/or execution of the proposed exercise; (iv) comorbidities that prevented upright posture and walking (e.g., hypotension); (v) refused consent or were unable to provide informed consent; (vi) recent bone fractures. In addition, we excluded patients if they had contraindications to the use of the technological instrumentation, such as a weight &#x0003e; 150 kg and open lesions or bandages in contact with the harness.</p><p>The enrolled patients were evaluated at baseline (T0) and after the experimental training (T1), consisting of forty sessions of RGT (experimental group&#x02014;EG) for eight consecutive weeks.</p><p>The data of these subjects were compared with those coming from a sample of 12 individuals (control group, CG) matched for clinical and demographic features who underwent the same amount of CGT with no robotic assistance, in addition to standard rehabilitation therapy.</p><p>All experiments were conducted according to the ethical policies and procedures approved by the local ethics committee (IRCCSME-45/2020 approved on 14/12/2020). All participants gave their written informed consent.</p><p>The clinical&#x02013;demographic characteristics of both groups are summarized in <xref rid="jfmk-10-00161-t001" ref-type="table">Table 1</xref>.</p><sec sec-type="methods" id="sec2dot1-jfmk-10-00161"><title>2.1. Procedures</title><p>All the included patients were submitted for the same amount of training. However, they diverged in the type of rehabilitation approaches. The EG (n. 12) underwent RGT with the G-EO system, while the CG (n. 12) received CGT. Both groups followed the same rehabilitation protocol (as per the total amount of training), consisting of five sessions per week over eight weeks (by our established clinical research and standard care protocols). Each session included approximately one hour of gait training, followed by 45 min of conventional physiotherapy. Importantly, while the duration and structure of the sessions were identical, the type of gait training differed between groups: the EG used the G-EO system, whereas the CG received conventional overground gait training. In addition to gait training, both groups also received conventional physiotherapy, including stretching exercises, passive and active-assisted limb mobilization, and therapeutic exercises aimed at improving range of motion and overall muscle strength, lasting approximately 45 min per session (see <xref rid="jfmk-10-00161-t002" ref-type="table">Table 2</xref> for more details).</p><p>All patients underwent a clinical visit and neurological evaluation at T0 and T1. However, only the patients who underwent RGT were also evaluated with the Fugl-Meyer&#x02014;Lower Extremity assessment to understand the effects of robotics on body segmental outcomes, as well as specific parameters coming from the device.</p></sec><sec id="sec2dot2-jfmk-10-00161"><title>2.2. Outcome Measures</title><p>Motor and functional clinical assessment scales/tests were administered by a skilled physiotherapist (ALF) at T0 and T1, and the subsequent analyses were performed by a biomedical engineer (PDP). In particular, the physiotherapist, who was blinded to the training allocation of the patient, administered a complete motor battery, including (i) the 10 Meters Walking Test (10MWT) [<xref rid="B18-jfmk-10-00161" ref-type="bibr">18</xref>] to assess walking speed in meters per second over a short distance; (ii) the Tinetti Scale (TS) [<xref rid="B19-jfmk-10-00161" ref-type="bibr">19</xref>], made up of 16 items, with 7 items assessing gait (with scores ranging from 0 to 12) and 9 items evaluating balance (with scores ranging from 0 to 16); (iii) the Modified Ashworth Scale (MAS) [<xref rid="B20-jfmk-10-00161" ref-type="bibr">20</xref>] was used to assess spasticity in lower limbs (hip, knee, and ankle), and it ranges from 0 (no increase in muscle tone) to 4 (rigid limb movement). Intermediate scores indicate varying degrees of increased muscle tone, from slight resistance (1, 1+) to marked stiffness (2, 3); (iv) the Functional Independence Measure (FIM) [<xref rid="B21-jfmk-10-00161" ref-type="bibr">21</xref>] was utilized to assess overall functioning across 18 items divided into six subscales&#x02014;self-care, sphincter control, transfer, locomotion, communication, and social cognition ability. A higher score indicates less disability for basic daily functions.</p><p>After the allocation assignment, EG patients were also evaluated with the Fugl-Meyer&#x02014;Lower Extremity (FMA-LE) assessment [<xref rid="B22-jfmk-10-00161" ref-type="bibr">22</xref>], which assesses reflexes and motor functioning at the hip, knee, and ankle (part E ranging from 0 to 28), coordination (part F ranging from 0 to 6), sensory functioning (part H ranging from 0 to 12), joint range of motion (part JI ranging from 0 to 20), and joint pain (part JII ranging from 0 to 20). In addition, specific rehabilitation parameters, regarding RGT, were extracted from the G-EO system, such as mean values of step cadence (steps/min) and walking speed (m/s).</p></sec><sec id="sec2dot3-jfmk-10-00161"><title>2.3. G-EO System</title><p>The G-EO system [<xref rid="B23-jfmk-10-00161" ref-type="bibr">23</xref>] is an advanced robotic end-effector designed specifically for lower limb rehabilitation. This innovative device is equipped with footplates, or pedals, that guide the movement of the lower limbs along fully programmable trajectories. These footplates are designed to facilitate a range of natural motion patterns, moving from the bottom to the top in a manner that closely mimics real-life walking. The system allows for precise adjustment of key parameters, including step length (from 0 to 55 cm), step height (up to 400 mm), footplate angles (up to 90 degrees), movement velocity (up to 2.3 km/h), and acceleration peaks (up to 10 m/s<sup>2</sup>). These customizable settings enable tailored rehabilitation programs that meet individual patient needs.</p><p>Unlike traditional systems that rely on the hips and knees for leg movement, the G-EO system focuses on ankle actuation, which is critical for simulating accurate walking mechanics. The patient&#x02019;s feet are securely fastened to the footplates using straps, ensuring proper alignment and safety during therapy sessions. This setup enables the device to replicate forward and backward walking motions, as well as stair-climbing activities, including both ascending and descending movements.</p><p>To enhance patient safety and support, the system features handrails on both sides, providing stability during therapy. Additionally, it incorporates a Body Weight Support (BWS) system, which reduces the load on the patient&#x02019;s lower limbs and allows for controlled weight-bearing exercises. This combination of features makes the G-EO system a highly versatile and effective tool for gait rehabilitation, offering a comprehensive approach to improving mobility and function in patients with lower limb impairments. The gait training session can be monitored through two displays providing visual feedback for therapists and patients. Moreover, this robotic device allows clinicians to supervise therapy progress over time through a detailed report, in which mean values of step length and cadence, walking speed, number of steps, and stairs are reported. In this way, therapists and clinicians can personalize each gait training session according to patients&#x02019; parameters. During the rehabilitation sessions conducted on the G-EO system, patients began walking at an initial comfortable pace. This velocity was incrementally increased by 0.1 m/s based on the motor capacity and the state of fatigability of the patients. Once this threshold was achieved, the main phase of the session began. This progressive approach was implemented daily, with adjustments made based on the patient&#x02019;s performance and safety. Additionally, the therapists were allowed to modify step length parameters to tailor the RGT session to each patient. The primary goal was to increase gait parameters such as step length and velocity within safe and effective ranges. If a patient demonstrated the ability to sustain these parameters, those parameters were retained for the session. If not, the training proceeded at the previously established parameters from the prior session. The intensity of the training was individualized to prevent overexertion, with patients being closely monitored by clinicians. In instances of noticeable fatigue, the walking speed was decreased to a more comfortable pace, ensuring the patient could continue training effectively without risking overfatigue or injury. In general, all the RGT sessions were supervised by the physiotherapist, providing support to the paretic knee of the patient as needed.</p><p>Initially, BWS was set at 80% discharge for both floor walking and stair climbing, gradually decreasing by 10% each week until reaching 10% or the highest tolerated BWS; however, individual adjustments were implemented as needed based on patient tolerance and fatigue to ensure a safe and effective progression. Refer to <xref rid="jfmk-10-00161-f001" ref-type="fig">Figure 1</xref> for a visual representation.</p></sec><sec id="sec2dot4-jfmk-10-00161"><title>2.4. Conventional Gait Training</title><p>Conventional gait training (CGT) sessions lasted one hour, followed by 45 min of conventional physiotherapy, in line with the protocol used for the EG (see <xref rid="jfmk-10-00161-t002" ref-type="table">Table 2</xref>).</p><p>In particular, the CGT included various exercises such as weight-shifting, core muscle strengthening, monopodal and bipodal balance exercises, and gait training involving obstacles, tandem, and slalom walking.</p><p>Like the EG, the intensity of training in the CG was individually tailored to prevent fatigue, with close monitoring of patients. Additionally, throughout all sessions, post-stroke patients received manual guidance and supervision from physiotherapists to minimize the risk of falls.</p></sec><sec id="sec2dot5-jfmk-10-00161"><title>2.5. Statistical Analysis</title><p>The sample participants&#x02019; sociodemographic and clinical parameters were analyzed, and differences between the experimental and control groups were assessed. Descriptive statistics were expressed as mean &#x000b1; standard deviation for continuous variables and as frequencies (percentages) for categorical variables. Age, years of education, and years since injury were treated as continuous variables, while gender, etiology, and most affected side were analyzed as categorical variables. Normality for continuous variables was tested using the Shapiro&#x02013;Wilk test (MATLAB R2022a, Natick, MA, USA, function swtest). Because the age distribution in both groups was normal, a parametric <italic toggle="yes">t</italic>-test (MATLAB function ttest) was used to evaluate group differences for age. In contrast, due to non-normal distributions of years of education and years since injury, group differences for these variables were assessed with the Mann&#x02013;Whitney U test (MATLAB function ranksum). For the categorical variables, contingency tables were constructed; Fisher&#x02019;s exact test (MATLAB function fishertest) was applied when expected frequencies were low, whereas a chi-squared test (MATLAB function chi2cdf) was used otherwise.</p><p>Clinical data collected before and after treatment were compared within both groups. First, normality was evaluated using the Shapiro&#x02013;Wilk test, and because not all distributions were normal, non-parametric methods were employed. Within-group changes were assessed with the Wilcoxon signed-rank test on paired pre-treatment (T0) and post-treatment (T1) data. To evaluate differences in treatment effects between groups, we computed the change (delta) for each subject (post-treatment value minus pre-treatment value) and compared these delta values between the experimental and control groups using the Mann&#x02013;Whitney U test (i.e., a rank-sum test on the pre&#x02013;post differences). Baseline equivalence was further confirmed by comparing the T0 values of the experimental group with those of the control group using the same non-parametric approach.</p><p>The dependency of clinical evaluations on demographic factors and patients&#x02019; clinical status was tested using linear mixed effects models (LMEs) [<xref rid="B24-jfmk-10-00161" ref-type="bibr">24</xref>] via MATLAB&#x02019;s fitlme function. Separate models were constructed for the experimental and control groups, with participants included as a random effect to account for inter-individual variability. The age (A), gender (G), time since injury (I), and session (S) were treated as fixed effect factors. The experimental factors G and S were treated with categorical (dummy) variables, as they could take categorical outcomes: G = 0 for male, G = 1 for female, S = 0 for T0, S = 1 for T1. RGT parameters, which were selected by the therapist as step cadence (C) and velocity (V) during therapy, were included in the EG model based on their established relevance as indicators of gait function and rehabilitation outcomes after stroke [<xref rid="B25-jfmk-10-00161" ref-type="bibr">25</xref>,<xref rid="B26-jfmk-10-00161" ref-type="bibr">26</xref>,<xref rid="B27-jfmk-10-00161" ref-type="bibr">27</xref>]. Moreover, the interactions between sessions and each variable were evaluated. The normality of the residuals, which supports the model choice, was verified using a Lilliefors test applied to the residuals.<disp-formula id="FD1-jfmk-10-00161"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>I</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b4;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b9;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>+</mml:mo><mml:mi>&#x003f5;</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="FD2-jfmk-10-00161"><label>(2)</label><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>I</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b4;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b6;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b7;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b9;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003bc;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mi>&#x003f5;</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>
<bold>Equations.</bold> In Equations (1) and (2), u<sub>0</sub> represents the individual intercept and accounts for interindividual differences. The coefficients &#x003b1;<sub>0</sub>, &#x003b2;<sub>0</sub>, &#x003b3;<sub>0</sub>, &#x003b4;<sub>0</sub>, &#x003b6;<sub>0</sub>, &#x003b7;<sub>0</sub>, &#x003b8;<sub>0</sub>, &#x003b9;<sub>0</sub>, &#x003ba;<sub>0</sub>, &#x003bb;<sub>0</sub>, and &#x003bc;<sub>0</sub> represent fixed effects; thus, the modulation of the response variable by the main factors A, G, I, S, C, V, and their interactions, <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="sans-serif">&#x003f5;</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is the error-term.</p><p>In both Equations (1) and (2), g represents the identity link function. Control data were fitted using Equation (1), while experimental data were fitted with Equation (2), which considers rehabilitation training input parameters. In both cases, model parameters were estimated using maximum likelihood.</p><p>The significance of each fixed-effect term in the models was tested using the Wald Test [<xref rid="B24-jfmk-10-00161" ref-type="bibr">24</xref>], which evaluates the contribution of each fixed effect based on its coefficients and associated covariance structure. Given the number of clinical outcome measures and fixed effects analyzed, the risk of inflated type I errors due to multiple comparisons was addressed by applying a False Discovery Rate (FDR) correction using the Benjamini&#x02013;Hochberg procedure [<xref rid="B28-jfmk-10-00161" ref-type="bibr">28</xref>].</p><p>The FDR correction was applied to the <italic toggle="yes">p</italic>-values obtained from the Wald tests at the term level, separately within each outcome-specific model. This correction method was applied independently for each clinical outcome, reflecting the independent testing of distinct functional domains.</p><p>Both uncorrected and FDR-corrected <italic toggle="yes">p</italic>-values are provided in the <xref rid="app1-jfmk-10-00161" ref-type="app">Supplementary Materials (Tables S1 and S2)</xref>. Statistical significance was based on FDR-corrected <italic toggle="yes">p</italic>-values; effects not surviving correction but with <italic toggle="yes">p</italic>-values close to the threshold were interpreted cautiously as indicative of trends.</p></sec></sec><sec sec-type="results" id="sec3-jfmk-10-00161"><title>3. Results</title><p>At the baseline, there were no significant differences in the demographic and clinical features between the groups, as shown in <xref rid="jfmk-10-00161-t001" ref-type="table">Table 1</xref>. All patients completed the trial, and none reported any side effects during or after the training.</p><p>We found that the TS evaluating balance and gait was significantly improved after (T1) the RGT in the EG (<italic toggle="yes">p</italic> = 0.012, <italic toggle="yes">p</italic> = 0.004). Regarding the 10MWT, we found a statistically significant improvement in the CG (<italic toggle="yes">p</italic> = 0.014), while the EG showed an increased score, without achieving statistical significance. Moreover, we found that independence in daily activities (FIM) in both groups (<italic toggle="yes">p</italic> &#x0003c; 0.001), as shown in <xref rid="jfmk-10-00161-t003" ref-type="table">Table 3</xref>.</p><p>On the other hand, the FMA scores also improved, especially in the motor function (items E-F) (E, <italic toggle="yes">p</italic> = 0.001, F, <italic toggle="yes">p</italic> = 0.031, E-F, <italic toggle="yes">p</italic> = 0.001) and in the passive range of motion (JI, <italic toggle="yes">p</italic> = 0.031), as shown in <xref rid="jfmk-10-00161-f002" ref-type="fig">Figure 2</xref>.</p><p>At the baseline, there were no significant differences in the clinical scales/tests scores between the two groups, as shown in <xref rid="jfmk-10-00161-t003" ref-type="table">Table 3</xref>. Regarding the statistical comparison between the two groups, we found statistically significant differences between EG and CG only in the TS for balance and gait (<italic toggle="yes">p</italic> = 0.003; <italic toggle="yes">p</italic> = 0.05), as shown in <xref rid="jfmk-10-00161-t003" ref-type="table">Table 3</xref>.</p><p>In particular, the EG showed a greater improvement in the TS for both balance and gait, compared to the CG, as shown in <xref rid="jfmk-10-00161-f003" ref-type="fig">Figure 3</xref>.</p><p>The analysis, conducted using an LME model and evaluated via the Wald Test, was performed to detect treatment-associated changes while simultaneously assessing the influence of various factors (age, gender, TSI, and session) on clinical outcomes. Additionally, for the experimental group, treatment-specific parameters, such as velocity and cadence, which were adjusted by the therapist session by session, were integrated into the model. This comprehensive approach enabled us to identify the parameters that most significantly influenced the success of the intervention, thereby providing valuable insights into the determinants of treatment efficacy. In this study, we have reported only the statistically significant effects detected by the model.</p><p>In the TS evaluating balance in the EG (R<sup>2</sup> = 0.98), significant effects were found for velocity (<italic toggle="yes">p</italic> = 0.049), gender &#x000d7; session (<italic toggle="yes">p</italic> = 0.049), TSI &#x000d7; session (<italic toggle="yes">p</italic> = 0.016), cadence &#x000d7; session (<italic toggle="yes">p</italic> = 0.016), and velocity &#x000d7; session (<italic toggle="yes">p</italic> = 0.016). Also, for the TS evaluating gait in the EG (R<sup>2</sup> = 0.98), significant effects were detected for session (<italic toggle="yes">p</italic> &#x0003c; 0.001), velocity (<italic toggle="yes">p</italic> &#x0003c; 0.001), gender &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001), and velocity &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001). In the control group (R<sup>2</sup> = 0.83), significant interactions were found for age &#x000d7; session (<italic toggle="yes">p</italic> = 0.019) and TSI &#x000d7; session (<italic toggle="yes">p</italic> = 0.024). For the MAS Scale in the EG (R<sup>2</sup> = 0.97), significant effects were observed for gender (<italic toggle="yes">p</italic> = 0.020), while a trend toward a significant effect of TSI (<italic toggle="yes">p</italic> = 0.074) was observed. Regarding the FIM Scale in the EG (R<sup>2</sup> = 0.98), we found that significant effects were observed for gender (<italic toggle="yes">p</italic> = 0.001), TSI (<italic toggle="yes">p</italic> &#x0003c; 0.001), cadence (<italic toggle="yes">p</italic> &#x0003c; 0.001), velocity (<italic toggle="yes">p</italic> =0.024), age &#x000d7; session (<italic toggle="yes">p</italic> = 0.024), gender &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001), and cadence &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001). On the other hand, in the CG (R<sup>2</sup> = 0.96), we found only the following significant effects: session (<italic toggle="yes">p</italic> = 0.023), TSI (<italic toggle="yes">p</italic> = 0.023), while a trend toward a significant effect of the interaction gender &#x000d7; session (<italic toggle="yes">p</italic> = 0.065) was observed. For FMA Item H in the EG (R<sup>2</sup> = 1), significant effects were detected for TSI (<italic toggle="yes">p</italic> = 0.019), velocity (<italic toggle="yes">p</italic> &#x0003c; 0.001), age &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001), and TSI &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001). For Item JI in the experimental group (R<sup>2</sup> = 0.97), significant effects were found for session (<italic toggle="yes">p</italic> &#x0003c; 0.001), TSI (<italic toggle="yes">p</italic> = 0.013), age &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001), gender &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001), TSI &#x000d7; session (<italic toggle="yes">p</italic> = 0.012), and a trend toward a significant effect of the interaction velocity &#x000d7; session (<italic toggle="yes">p</italic> = 0.079) was observed. For Item JII in the experimental group (R<sup>2</sup> = 0.93), significant effects were observed for TSI (<italic toggle="yes">p</italic> &#x0003c; 0.001), cadence (<italic toggle="yes">p</italic> = 0.017), and TSI &#x000d7; session (<italic toggle="yes">p</italic> &#x0003c; 0.001).</p><p>Although the effect on the 10MWT evaluation in the EG (R<sup>2</sup> = 0.99) did not reach statistical significance after FDR correction, a trend toward significance was observed for the following interactions: gender &#x000d7; session (<italic toggle="yes">p</italic> = 0.073), TSI &#x000d7; session (<italic toggle="yes">p</italic> = 0.089), and cadence &#x000d7; session (<italic toggle="yes">p</italic> = 0.073).</p></sec><sec sec-type="discussion" id="sec4-jfmk-10-00161"><title>4. Discussion</title><p>In this case-control study, we aimed to investigate the effects of rehabilitation with the G-EO system, a robotic end-effector, on lower limb function in chronic post-stroke patients, compared to a CG that received CGT. At baseline, no significant differences were observed between groups in demographic and clinical characteristics. However, following the intervention, the EG demonstrated significant improvements in balance and gait performance (TS evaluating gait and balance, see <xref rid="jfmk-10-00161-f003" ref-type="fig">Figure 3</xref>), as well as significant differences compared to the CG. These results may indicate that RGT enhanced postural control and dynamic stability, likely due to its ability to provide task-specific and repetitive movement patterns, which might facilitate neuromuscular adaptation (as demonstrated by previous studies [<xref rid="B29-jfmk-10-00161" ref-type="bibr">29</xref>,<xref rid="B30-jfmk-10-00161" ref-type="bibr">30</xref>]). In line with our findings, Kim et al. [<xref rid="B31-jfmk-10-00161" ref-type="bibr">31</xref>] found that RGT with an end-effector, combined with conventional physiotherapy, was associated with an improvement in balance scores, in comparison with CGT alone. According to the literature [<xref rid="B2-jfmk-10-00161" ref-type="bibr">2</xref>,<xref rid="B5-jfmk-10-00161" ref-type="bibr">5</xref>,<xref rid="B32-jfmk-10-00161" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00161" ref-type="bibr">33</xref>], lower limb alterations (e.g., muscle stiffness, spasticity, sensory loss) in post-stroke patients can be associated with a reduced efficiency in gait and balance, leading to an increased risk of falls in this patient population. In this context, neurorehabilitation strategies aim to achieve better neuromuscular control of lower limbs to promote a higher level of independence [<xref rid="B34-jfmk-10-00161" ref-type="bibr">34</xref>]. Innovative technologies, like robotic devices, have the advantage of carrying out personalized and task-oriented training that can motivate the patients, leading to longer therapy sessions [<xref rid="B8-jfmk-10-00161" ref-type="bibr">8</xref>]. Specifically, end-effector robotic devices are stationary devices with a distal movable part requiring active participation. In particular, the end-effectors are suitable tools that can be adapted to different shapes and sizes. Our results are likely influenced by the suitability of end-effector devices for patients who had residual locomotor functions, indicating a sufficient activation of proximal joints and muscles. It is noteworthy that the G-EO system provides repetitive, intensive, and task-oriented training that can enhance motor learning by engaging both efferent motor pathways and afferent sensory pathways throughout the training process [<xref rid="B35-jfmk-10-00161" ref-type="bibr">35</xref>]. Repetitive movements guided by the robotic device can play a crucial role in the re-acquisition of motor functions, promoting muscle memory and improving motor coordination [<xref rid="B35-jfmk-10-00161" ref-type="bibr">35</xref>]. It has been demonstrated that repetitive motor tasks facilitate neuroplasticity and brain reorganization in stroke patients, resulting in enhanced motor recovery after stroke [<xref rid="B36-jfmk-10-00161" ref-type="bibr">36</xref>]. In addition, the G-EO system promotes proximal muscle activity. In this sense, some authors found that proximal lower limb control plays a key role in improving gait speed and walking performance after stroke [<xref rid="B36-jfmk-10-00161" ref-type="bibr">36</xref>]. In this regard, we found that the RGT session with the G-EO system influenced the 10MWT scores in the EG. However, we did not find statistically significant differences between CG and EG in gait speed, maybe due to the small sample. Moreover, other authors studied the effects of RGT in chronic stroke patients with Lokomat, an exoskeleton, suggesting that FMA scores were significantly different in comparison with the conventional rehabilitation group. However, no significant differences in other clinical scales or tests were found in both groups. According to our results, RGT with the G-EO system improved FMA-LE scores, especially lower limb movements (FMA-LE part E), coordination (FMA-LE part F), and joint passive range of motion (FMA-LE part JI). This aspect could be explained by the fact that repetitive movements, provided by the robotic device, can serve as a fundamental element in the acquisition of motor skills [<xref rid="B37-jfmk-10-00161" ref-type="bibr">37</xref>], improving motor coordination and precision over time. A key outcome of this study was the improvement in functional independence (FIM) in both groups. This suggests that while both RGT and conventional therapy contribute to functional recovery, RGT with the G-EO system may offer additional benefits, allowing for the simulation of real-world experiences, such as ascending and descending stairs. In this way, by incorporating different stimuli and environmental conditions, therapy sessions become more dynamic and reflect the challenges encountered in everyday life [<xref rid="B38-jfmk-10-00161" ref-type="bibr">38</xref>], explaining our improvements in FIM scores.</p><p>The LME analysis showed that RGT treatment parameters (e.g., velocity and cadence) had significant effects across different assessment scales, indicating that adjustments made during the intervention have a dynamic impact on motor function recovery. In addition, as the LME analysis revealed that patients&#x02019; demographic and clinical characteristics influenced various assessment scales, these findings underscore the importance of adopting a personalized rehabilitation approach that considers both baseline characteristics and adaptive treatment strategies to optimize motor recovery. Moreover, some clinical scales, such as FMA, showed significant interactions between sessions and various fixed effects. For instance, we found a significant session &#x000d7; age interaction (FMA, items H and JI), suggesting that the magnitude or pattern of motor recovery differs across age groups, with younger patients potentially exhibiting a more pronounced improvement than older patients.</p><p>This aspect is particularly important, as in the acute and subacute phases of stroke, it appears that there is no significant difference in motor and cognitive recovery between younger and older patients. Several studies, including the one by Kugler et al. [<xref rid="B39-jfmk-10-00161" ref-type="bibr">39</xref>], have demonstrated that age is a poor predictor of functional recovery during these early stages. However, in the chronic phase of stroke, age seems to play a more substantial role. Yoo et al. [<xref rid="B40-jfmk-10-00161" ref-type="bibr">40</xref>] found that functional recovery between 6- and 30-months post-stroke differed significantly between patients younger than 70 years and those aged 70 years or older.</p><p>Moreover, we found a statistically significant effect of velocity and an interaction between velocity and session on gait and balance outcomes (TS), as well as the effect of the interaction between cadence and session on balance outcome (TS for balance). According to Tomida et al. [<xref rid="B41-jfmk-10-00161" ref-type="bibr">41</xref>], increasing walking speed on a treadmill can significantly increase cadence in post-stroke patients. Generally, in healthy individuals, increasing gait speed requires taking longer steps, which necessitates moving the leg forward more quickly [<xref rid="B42-jfmk-10-00161" ref-type="bibr">42</xref>]. On the other hand, in post-stroke patients, enhancing propulsive force and facilitating a rapid forward swing of the lower limbs, achieved through an increased push-off moment via ankle plantar flexion during the late stance phase, augmented pull-off via hip flexion in the initial swing phase, and greater angular velocity, are key factors in improving walking speed [<xref rid="B41-jfmk-10-00161" ref-type="bibr">41</xref>].</p><p>Walking with end-effectors allows high degrees of freedom motions, which may provide a more realistic gait [<xref rid="B43-jfmk-10-00161" ref-type="bibr">43</xref>]. This aspect could have increased the passive range of motion scores in FMA-LE (FMA item JI), suggesting that the G-EO promoted an effective recovery instead of relying solely on behavioral compensation mechanisms. Furthermore, the significant effects and potential trends identified in passive range of motion (FMA item JI) and joint pain (FMA item JII) highlight the complex interplay between intrinsic patient characteristics and the optimization of tailored treatment parameters.</p><p>Unlike conventional rehabilitation training, the RGT with the G-EO offers visual feedback for patients and therapists. In this way, patients could have exploited the visual cues on the screen to increase their motivation during the training session. According to Nascimento et al. [<xref rid="B44-jfmk-10-00161" ref-type="bibr">44</xref>], walking training accompanied by cues for cadence can be an effective rehabilitation strategy to positively affect cadence, speed, and step length. On the other hand, the 10MWT showed a significant improvement in the CG, while the EG exhibited an increased score without reaching statistical significance. This finding suggests that CGT may still be more effective for certain aspects of mobility.</p><p>Similar findings were reported by Goffredo et al. [<xref rid="B45-jfmk-10-00161" ref-type="bibr">45</xref>], where the 10MWT did not show significant improvement in the RGT group treated either with an end-effector or with an exoskeleton, while the CGT group achieved statistical significance in this test. Likewise, in the study by Aprile et al. [<xref rid="B14-jfmk-10-00161" ref-type="bibr">14</xref>], the 10MWT did not yield any significant differences between T0 and T1 in either the RGT or CGT groups.</p><p>However, in our study, the LME analysis revealed a potential trend of the following interactions: age &#x000d7; session, gender &#x000d7; session, TSI &#x000d7; session, and cadence &#x000d7; session in the EG, related to the 10MWT, indicating that considering both demographic and clinical patients characteristics as well as RGT training parameters can positively affect the outcomes over time.</p><p>Among the interactions identified in the 10MWT evaluation for the EG, the cadence &#x000d7; session is particularly noteworthy. This finding potentially indicates that changes in cadence throughout the treatment could be significantly associated with improvements in walking performance [<xref rid="B44-jfmk-10-00161" ref-type="bibr">44</xref>]. Given that cadence represents the rhythm and pace of steps [<xref rid="B46-jfmk-10-00161" ref-type="bibr">46</xref>], a critical element of effective gait, the significant interaction suggests that adjustments made to cadence during each session contributed meaningfully to overall performance gains [<xref rid="B47-jfmk-10-00161" ref-type="bibr">47</xref>]. Specifically, the dynamic modulation of cadence, which was tailored by the therapist on a session-by-session basis, appears to have played a crucial role in enhancing neuromuscular coordination and gait efficiency. As the treatment progressed, the evolving relationship between cadence and session highlighted its potential as both a therapeutic target and a sensitive indicator of treatment responsiveness. In essence, these results underscore the importance of personalized adjustments in cadence to optimize rehabilitation outcomes, suggesting that fine-tuning this parameter could be key to achieving more effective gait training in patients undergoing robotic-assisted interventions [<xref rid="B48-jfmk-10-00161" ref-type="bibr">48</xref>,<xref rid="B49-jfmk-10-00161" ref-type="bibr">49</xref>].</p><p>Regarding muscle tone and motor control, both the EG and CG exhibited lower MAS scores post-treatment compared to baseline, indicating a reduction in spasticity. However, while the overall improvement in MAS scores was not statistically significant in the CG, the EG demonstrated statistically significant effects of gender and a trend toward a significant effect of TSI.</p><p>These findings suggest that, although both interventions led to a decrease in muscle tone, RGT may have a more pronounced impact on reducing spasticity in certain subgroups of patients [<xref rid="B15-jfmk-10-00161" ref-type="bibr">15</xref>]. In particular, the effect of gender and TSI can modulate the response of the MAS to robotic-assisted therapy, underscoring the potential for a more patient-specific rehabilitation approach.</p><p>According to a previous study in the multiple sclerosis population [<xref rid="B35-jfmk-10-00161" ref-type="bibr">35</xref>], the RGT with the G-EO system showed that MAS scores were significantly improved compared to the CGT. It has been suggested that RGT, by stimulating neuroplastic processes, may help regulate corticospinal excitability mechanisms involved in spasticity [<xref rid="B8-jfmk-10-00161" ref-type="bibr">8</xref>,<xref rid="B35-jfmk-10-00161" ref-type="bibr">35</xref>]. Spasticity is characterized by an increase in velocity-dependent tonic stretch reflexes, often associated with exaggerated tendon jerks [<xref rid="B50-jfmk-10-00161" ref-type="bibr">50</xref>]. From this perspective, the repetitive movements performed at a tolerated speed, according to the patients&#x02019; needs, during RGT could mitigate spasticity by engaging spinal locomotor centers and influencing corticospinal pathway activity.</p><p>Our study has some limitations that should be acknowledged. First, the main limitation is related to the lack of randomization. Randomized trials (RCTs) allow for an unbiased assessment of treatment effects and ensure that, on average, treatment groups are balanced across all covariates. Secondly, the small sample prevents us from generalizing our findings. In this context, future larger sample RCTs on RGT in chronic post-stroke patients should be designed to minimize selection bias. Increasing the sample size would enhance the statistical power to confirm the positive trend of our study. Furthermore, we employed a demographic matching approach in our case-control design, which offers more limited control over potential confounding factors. Unlike simple demographic matching, propensity score matching accounts for multiple covariates simultaneously to achieve a more comprehensive balance between groups. In our study, the two groups were mostly balanced, although the TS gait at baseline was close to reaching statistical significance. Therefore, future studies should aim for greater homogeneity between groups to improve comparability and reduce potential confounding effects.</p><p>Future research should incorporate quantitative gait analysis methods, such as motion capture systems, force plates, and electromyography, to provide deeper insights into the effects and underlying mechanisms of motor recovery during RGT in chronic stroke patients. It is also important to implement clinical and quantitative evaluations not only in the short term but also in the long term through appropriate follow-up assessments. Lastly, we cannot exclude the possibility that the RGT group experienced a psychological placebo effect as compared to the non-robotic group, potentially influencing the results. However, unlike pharmacological or neuromodulation studies, where sham treatments can be implemented to control placebo effects, rehabilitation research faces inherent limitations: patients are fully aware of the type of intervention they receive, making it difficult to eliminate such biases.</p><p>Our study was intended to be preliminary evidence focusing on the feasibility and potential effectiveness of RGT with an end-effector in post-stroke patients compared to conventional gait training to provide basic information on determining the appropriateness of candidates that could benefit from this kind of treatment.</p></sec><sec sec-type="conclusions" id="sec5-jfmk-10-00161"><title>5. Conclusions</title><p>In conclusion, our results suggest that RGT with end-effectors, such as the G-EO system, may serve as an adjunctive and complementary treatment in neurorehabilitation, even for patients with chronic stroke, where recovery is typically considered to have plateaued. According to our findings, the G-EO system improved gait and balance functions compared to CGT. Furthermore, RGT promoted improvements in lower limb motor functions, indicating enhanced motor control and coordination, which are both key factors in fall prevention.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-jfmk-10-00161"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/jfmk10020161/s1">https://www.mdpi.com/article/10.3390/jfmk10020161/s1</uri>, Table S1: Results of linear mixed effects models for the experimental group (RGT): corrected and uncorrected <italic toggle="yes">p</italic>-values and significance for each clinical outcome. The table reports the results of linear mixed effects models (LMEs) for each clinical outcome in the experimental group. For each model, <italic toggle="yes">p</italic>-values obtained from Wald tests at the term level and their corresponding false discovery rate (FDR)-corrected values are presented, along with the assigned significance symbols. Statistical significance is indicated as *** <italic toggle="yes">p</italic> &#x0003c; 0.001, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, * <italic toggle="yes">p</italic> &#x0003c; 0.05 after FDR correction, &#x02020; indicates results significant before but not after correction, ns denotes non-significant effects; Table S2: Results of linear mixed effects models for the control group (CGT): corrected and uncorrected <italic toggle="yes">p</italic>-values and significance for each clinical outcome. The table reports the results of linear mixed effects models (LMEs) for each clinical outcome in the experimental group. For each model, <italic toggle="yes">p</italic>-values obtained from Wald tests at the term level and their corresponding false discovery rate (FDR)-corrected values are presented, along with the assigned significance symbols. Statistical significance is indicated as *** <italic toggle="yes">p</italic> &#x0003c; 0.001, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, * <italic toggle="yes">p</italic> &#x0003c; 0.05 after FDR correction, &#x02020; indicates results significant before but not after correction, ns denotes non-significant effects.</p><supplementary-material id="jfmk-10-00161-s001" position="float" content-type="local-data"><media xlink:href="jfmk-10-00161-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, M.B., P.D.P., and R.S.C.; methodology, A.L.F. and P.D.P.; software, P.D.P.; validation, all authors; formal analysis, P.D.P.; investigation, M.B., B.D., and A.L.F.; resources, A.Q. and R.S.C.; data curation, P.D.P. and A.L.F.; writing&#x02014;original draft preparation, M.B., P.D.P., and R.D.L.; writing&#x02014;review and editing, R.S.C.; visualization, all authors; supervision, R.S.C., A.Q., and R.D.L.; project administration, A.Q. and R.S.C.; funding acquisition, A.Q. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in accordance with the Declaration of Helsinki and approved by the local Ethics Committee, IRCCS Centro Neurolesi Bonino Pulejo (IRCCSME-45-2020, 12 December 2020).</p></notes><notes><title>Informed Consent Statement</title><p>Written and informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to the privacy of research participants.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">10MWT</td><td align="left" valign="middle" rowspan="1" colspan="1">10 Meters Walking Test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BWS</td><td align="left" valign="middle" rowspan="1" colspan="1">Body Weight Support</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CG</td><td align="left" valign="middle" rowspan="1" colspan="1">Control Group</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CGT</td><td align="left" valign="middle" rowspan="1" colspan="1">Conventional Gait Training</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EG</td><td align="left" valign="middle" rowspan="1" colspan="1">Experimental Group</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FAC</td><td align="left" valign="middle" rowspan="1" colspan="1">Functional Ambulation Classification</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FDR</td><td align="left" valign="middle" rowspan="1" colspan="1">False Discovery Rate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FIM</td><td align="left" valign="middle" rowspan="1" colspan="1">Functional Independence Measure</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FMA-LE</td><td align="left" valign="middle" rowspan="1" colspan="1">Fugl-Meyer Assessment&#x02014;Lower Extremity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LME</td><td align="left" valign="middle" rowspan="1" colspan="1">Linear Mixed Effects</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAS</td><td align="left" valign="middle" rowspan="1" colspan="1">Modified Ashworth Scale</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RGT</td><td align="left" valign="middle" rowspan="1" colspan="1">Robotic Gait Training</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">T0</td><td align="left" valign="middle" rowspan="1" colspan="1">Baseline Timepoint</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">T1</td><td align="left" valign="middle" rowspan="1" colspan="1">Post-Treatment Timepoint</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TS</td><td align="left" valign="middle" rowspan="1" colspan="1">Tinetti Scale</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TSI</td><td align="left" valign="middle" rowspan="1" colspan="1">Time Since Injury</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-jfmk-10-00161"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohan</surname><given-names>D.M.</given-names></name>
<name><surname>Khandoker</surname><given-names>A.H.</given-names></name>
<name><surname>Wasti</surname><given-names>S.A.</given-names></name>
<name><surname>Ismail Ibrahim Ismail Alali</surname><given-names>S.</given-names></name>
<name><surname>Jelinek</surname><given-names>H.F.</given-names></name>
<name><surname>Khalaf</surname><given-names>K.</given-names></name>
</person-group><article-title>Assessment Methods of Post-Stroke Gait: A Scoping Review of Technology-Driven Approaches to Gait Characterization and Analysis</article-title><source>Front. Neurol.</source><year>2021</year><volume>12</volume><elocation-id>650024</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2021.650024</pub-id><pub-id pub-id-type="pmid">34168608</pub-id>
</element-citation></ref><ref id="B2-jfmk-10-00161"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mizuta</surname><given-names>N.</given-names></name>
<name><surname>Hasui</surname><given-names>N.</given-names></name>
<name><surname>Kai</surname><given-names>T.</given-names></name>
<name><surname>Inui</surname><given-names>Y.</given-names></name>
<name><surname>Sato</surname><given-names>M.</given-names></name>
<name><surname>Ohnishi</surname><given-names>S.</given-names></name>
<name><surname>Taguchi</surname><given-names>J.</given-names></name>
<name><surname>Nakatani</surname><given-names>T.</given-names></name>
</person-group><article-title>Characteristics of Limb Kinematics in the Gait Disorders of Post-Stroke Patients</article-title><source>Sci. Rep.</source><year>2024</year><volume>14</volume><elocation-id>3082</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-024-53616-w</pub-id><pub-id pub-id-type="pmid">38321081</pub-id>
</element-citation></ref><ref id="B3-jfmk-10-00161"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonanno</surname><given-names>M.</given-names></name>
<name><surname>De Nunzio</surname><given-names>A.M.</given-names></name>
<name><surname>Quartarone</surname><given-names>A.</given-names></name>
<name><surname>Militi</surname><given-names>A.</given-names></name>
<name><surname>Petralito</surname><given-names>F.</given-names></name>
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Gait Analysis in Neurorehabilitation: From Research to Clinical Practice</article-title><source>Bioengineering</source><year>2023</year><volume>10</volume><elocation-id>785</elocation-id><pub-id pub-id-type="doi">10.3390/bioengineering10070785</pub-id><pub-id pub-id-type="pmid">37508812</pub-id>
</element-citation></ref><ref id="B4-jfmk-10-00161"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Mukaino</surname><given-names>M.</given-names></name>
<name><surname>Ohtsuka</surname><given-names>K.</given-names></name>
<name><surname>Otaka</surname><given-names>Y.</given-names></name>
<name><surname>Tanikawa</surname><given-names>H.</given-names></name>
<name><surname>Matsuda</surname><given-names>F.</given-names></name>
<name><surname>Tsuchiyama</surname><given-names>K.</given-names></name>
<name><surname>Yamada</surname><given-names>J.</given-names></name>
<name><surname>Saitoh</surname><given-names>E.</given-names></name>
</person-group><article-title>Gait Characteristics of Post-Stroke Hemiparetic Patients with Different Walking Speeds</article-title><source>Int. J. Rehabil. Res.</source><year>2020</year><volume>43</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1097/MRR.0000000000000391</pub-id><pub-id pub-id-type="pmid">31855899</pub-id>
</element-citation></ref><ref id="B5-jfmk-10-00161"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weerdesteyn</surname><given-names>V.</given-names></name>
<name><surname>de Niet</surname><given-names>M.</given-names></name>
<name><surname>van Duijnhoven</surname><given-names>H.J.R.</given-names></name>
<name><surname>Geurts</surname><given-names>A.C.H.</given-names></name>
</person-group><article-title>Falls in Individuals with Stroke</article-title><source>J. Rehabil. Res. Dev.</source><year>2008</year><volume>45</volume><fpage>1195</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1682/JRRD.2007.09.0145</pub-id><pub-id pub-id-type="pmid">19235120</pub-id>
</element-citation></ref><ref id="B6-jfmk-10-00161"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>K.B.</given-names></name>
<name><surname>Kim</surname><given-names>J.S.</given-names></name>
<name><surname>Hong</surname><given-names>B.Y.</given-names></name>
<name><surname>Sul</surname><given-names>B.</given-names></name>
<name><surname>Song</surname><given-names>S.</given-names></name>
<name><surname>Sung</surname><given-names>W.J.</given-names></name>
<name><surname>Hwang</surname><given-names>B.Y.</given-names></name>
<name><surname>Lim</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Brain Lesions Affecting Gait Recovery in Stroke Patients</article-title><source>Brain Behav.</source><year>2017</year><volume>7</volume><fpage>e00868</fpage><pub-id pub-id-type="doi">10.1002/brb3.868</pub-id><pub-id pub-id-type="pmid">29201557</pub-id>
</element-citation></ref><ref id="B7-jfmk-10-00161"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pollock</surname><given-names>A.</given-names></name>
<name><surname>Baer</surname><given-names>G.</given-names></name>
<name><surname>Campbell</surname><given-names>P.</given-names></name>
<name><surname>Choo</surname><given-names>P.L.</given-names></name>
<name><surname>Forster</surname><given-names>A.</given-names></name>
<name><surname>Morris</surname><given-names>J.</given-names></name>
<name><surname>Pomeroy</surname><given-names>V.M.</given-names></name>
<name><surname>Langhorne</surname><given-names>P.</given-names></name>
</person-group><article-title>Physical Rehabilitation Approaches for the Recovery of Function and Mobility Following Stroke</article-title><source>Cochrane Database Syst. Rev.</source><year>2014</year><volume>2014</volume><fpage>CD001920</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD001920.pub3</pub-id><pub-id pub-id-type="pmid">24756870</pub-id>
</element-citation></ref><ref id="B8-jfmk-10-00161"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
<name><surname>Sorrentino</surname><given-names>G.</given-names></name>
<name><surname>Cassio</surname><given-names>A.</given-names></name>
<name><surname>Mazzoli</surname><given-names>D.</given-names></name>
<name><surname>Andrenelli</surname><given-names>E.</given-names></name>
<name><surname>Bizzarini</surname><given-names>E.</given-names></name>
<name><surname>Campanini</surname><given-names>I.</given-names></name>
<name><surname>Carmignano</surname><given-names>S.M.</given-names></name>
<name><surname>Cerulli</surname><given-names>S.</given-names></name>
<name><surname>Chisari</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Robotic-Assisted Gait Rehabilitation Following Stroke: A Systematic Review of Current Guidelines and Practical Clinical Recommendations</article-title><source>Eur. J. Phys. Rehabil. Med.</source><year>2021</year><volume>57</volume><fpage>460</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.23736/S1973-9087.21.06887-8</pub-id><pub-id pub-id-type="pmid">33947828</pub-id>
</element-citation></ref><ref id="B9-jfmk-10-00161"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ward</surname><given-names>N.S.</given-names></name>
<name><surname>Brown</surname><given-names>M.M.</given-names></name>
<name><surname>Thompson</surname><given-names>A.J.</given-names></name>
<name><surname>Frackowiak</surname><given-names>R.S.J.</given-names></name>
</person-group><article-title>Neural Correlates of Motor Recovery after Stroke: A Longitudinal fMRI Study</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>2476</fpage><lpage>2496</lpage><pub-id pub-id-type="doi">10.1093/brain/awg245</pub-id><pub-id pub-id-type="pmid">12937084</pub-id>
</element-citation></ref><ref id="B10-jfmk-10-00161"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Manuli</surname><given-names>A.</given-names></name>
<name><surname>Maggio</surname><given-names>M.G.</given-names></name>
<name><surname>Latella</surname><given-names>D.</given-names></name>
<name><surname>Cannav&#x000f2;</surname><given-names>A.</given-names></name>
<name><surname>Balletta</surname><given-names>T.</given-names></name>
<name><surname>De Luca</surname><given-names>R.</given-names></name>
<name><surname>Naro</surname><given-names>A.</given-names></name>
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Can Robotic Gait Rehabilitation plus Virtual Reality Affect Cognitive and Behavioural Outcomes in Patients with Chronic Stroke? A Randomized Controlled Trial Involving Three Different Protocols</article-title><source>J. Stroke Cerebrovasc. Dis.</source><year>2020</year><volume>29</volume><fpage>104994</fpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2020.104994</pub-id><pub-id pub-id-type="pmid">32689601</pub-id>
</element-citation></ref><ref id="B11-jfmk-10-00161"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
<name><surname>Naro</surname><given-names>A.</given-names></name>
<name><surname>Russo</surname><given-names>M.</given-names></name>
<name><surname>Leo</surname><given-names>A.</given-names></name>
<name><surname>De Luca</surname><given-names>R.</given-names></name>
<name><surname>Balletta</surname><given-names>T.</given-names></name>
<name><surname>Buda</surname><given-names>A.</given-names></name>
<name><surname>La Rosa</surname><given-names>G.</given-names></name>
<name><surname>Bramanti</surname><given-names>A.</given-names></name>
<name><surname>Bramanti</surname><given-names>P.</given-names></name>
</person-group><article-title>The Role of Virtual Reality in Improving Motor Performance as Revealed by EEG: A Randomized Clinical Trial</article-title><source>J. Neuroeng. Rehabil.</source><year>2017</year><volume>14</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1186/s12984-017-0268-4</pub-id><pub-id pub-id-type="pmid">28592282</pub-id>
</element-citation></ref><ref id="B12-jfmk-10-00161"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Bonanno</surname><given-names>M.</given-names></name>
<name><surname>Pioggia</surname><given-names>G.</given-names></name>
<name><surname>Santamato</surname><given-names>A.</given-names></name>
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Robotics in Neurorehabilitation: From Research to Clinical Practice</article-title><source>Translational Neurorehabilitation: Brain, Behavior and Technology</source><person-group person-group-type="editor">
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
</person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2024</year><fpage>165</fpage><lpage>174</lpage><isbn>978-3-031-63604-2</isbn></element-citation></ref><ref id="B13-jfmk-10-00161"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>P.</given-names></name>
<name><surname>Deshpande</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Exoskeletons: State-of-the-Art, Design Challenges, and Future Directions</article-title><source>Human Performance Optimization: The Science and Ethics of Enhancing Human Capabilities</source><person-group person-group-type="editor">
<name><surname>Matthews</surname><given-names>M.D.</given-names></name>
<name><surname>Schnyer</surname><given-names>D.M.</given-names></name>
</person-group><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>2019</year><isbn>978-0-19-045513-2</isbn></element-citation></ref><ref id="B14-jfmk-10-00161"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aprile</surname><given-names>I.</given-names></name>
<name><surname>Iacovelli</surname><given-names>C.</given-names></name>
<name><surname>Padua</surname><given-names>L.</given-names></name>
<name><surname>Galafate</surname><given-names>D.</given-names></name>
<name><surname>Criscuolo</surname><given-names>S.</given-names></name>
<name><surname>Gabbani</surname><given-names>D.</given-names></name>
<name><surname>Cruciani</surname><given-names>A.</given-names></name>
<name><surname>Germanotta</surname><given-names>M.</given-names></name>
<name><surname>Di Sipio</surname><given-names>E.</given-names></name>
<name><surname>De Pisi</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Efficacy of Robotic-Assisted Gait Training in Chronic Stroke Patients: Preliminary Results of an Italian Bi-Centre Study</article-title><source>NeuroRehabilitation</source><year>2017</year><volume>41</volume><fpage>775</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.3233/NRE-172156</pub-id><pub-id pub-id-type="pmid">28946585</pub-id>
</element-citation></ref><ref id="B15-jfmk-10-00161"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aprile</surname><given-names>I.</given-names></name>
<name><surname>Iacovelli</surname><given-names>C.</given-names></name>
<name><surname>Goffredo</surname><given-names>M.</given-names></name>
<name><surname>Cruciani</surname><given-names>A.</given-names></name>
<name><surname>Galli</surname><given-names>M.</given-names></name>
<name><surname>Simbolotti</surname><given-names>C.</given-names></name>
<name><surname>Pecchioli</surname><given-names>C.</given-names></name>
<name><surname>Padua</surname><given-names>L.</given-names></name>
<name><surname>Galafate</surname><given-names>D.</given-names></name>
<name><surname>Pournajaf</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Efficacy of End-Effector Robot-Assisted Gait Training in Subacute Stroke Patients: Clinical and Gait Outcomes from a Pilot Bi-Centre Study</article-title><source>NeuroRehabilitation</source><year>2019</year><volume>45</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.3233/NRE-192778</pub-id><pub-id pub-id-type="pmid">31498139</pub-id>
</element-citation></ref><ref id="B16-jfmk-10-00161"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>D.Y.</given-names></name>
<name><surname>Chun</surname><given-names>M.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.W.</given-names></name>
<name><surname>Jeon</surname><given-names>H.R.</given-names></name>
<name><surname>Hwang</surname><given-names>C.H.</given-names></name>
<name><surname>Choi</surname><given-names>J.K.</given-names></name>
<name><surname>Bae</surname><given-names>S.</given-names></name>
</person-group><article-title>Effects of Robot-(Morning Walk<sup>&#x000ae;</sup>) Assisted Gait Training for Patients after Stroke: A Randomized Controlled Trial</article-title><source>Clin. Rehabil.</source><year>2019</year><volume>33</volume><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1177/0269215518806563</pub-id><pub-id pub-id-type="pmid">30326747</pub-id>
</element-citation></ref><ref id="B17-jfmk-10-00161"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>D.Y.</given-names></name>
<name><surname>Lee</surname><given-names>S.H.</given-names></name>
<name><surname>Kim</surname><given-names>J.H.</given-names></name>
<name><surname>Kim</surname><given-names>D.Y.</given-names></name>
<name><surname>Lim</surname><given-names>K.-B.</given-names></name>
<name><surname>Yoo</surname><given-names>J.</given-names></name>
</person-group><article-title>End-Effector Lower Limb Robot-Assisted Gait Training Effects in Subacute Stroke Patients: A Randomized Controlled Pilot Trial</article-title><source>Medicine</source><year>2023</year><volume>102</volume><fpage>e35568</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000035568</pub-id><pub-id pub-id-type="pmid">37861512</pub-id>
</element-citation></ref><ref id="B18-jfmk-10-00161"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>D.K.-Y.</given-names></name>
<name><surname>Dagenais</surname><given-names>M.</given-names></name>
<name><surname>Alsbury-Nealy</surname><given-names>K.</given-names></name>
<name><surname>Legasto</surname><given-names>J.M.</given-names></name>
<name><surname>Scodras</surname><given-names>S.</given-names></name>
<name><surname>Aravind</surname><given-names>G.</given-names></name>
<name><surname>Takhar</surname><given-names>P.</given-names></name>
<name><surname>Nekolaichuk</surname><given-names>E.</given-names></name>
<name><surname>Salbach</surname><given-names>N.M.</given-names></name>
</person-group><article-title>Distance-Limited Walk Tests Post-Stroke: A Systematic Review of Measurement Properties</article-title><source>NeuroRehabilitation</source><year>2021</year><volume>48</volume><fpage>413</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.3233/NRE-210026</pub-id><pub-id pub-id-type="pmid">33967070</pub-id>
</element-citation></ref><ref id="B19-jfmk-10-00161"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tinetti</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Performance-oriented assessment of mobility problems in elderly patients</article-title><source>J. Am. Geriatrics Soc.</source><year>1986</year><volume>34</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.1986.tb05480.x</pub-id></element-citation></ref><ref id="B20-jfmk-10-00161"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Harb</surname><given-names>A.</given-names></name>
<name><surname>Kishner</surname><given-names>S.</given-names></name>
</person-group><article-title>Modified Ashworth Scale</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2025</year></element-citation></ref><ref id="B21-jfmk-10-00161"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Biester</surname><given-names>R.C.</given-names></name>
</person-group><article-title>Chapter 12&#x02014;Outcome Scales and Neuropsychological Outcome</article-title><source>Monitoring in Neurocritical Care</source><person-group person-group-type="editor">
<name><surname>Le Roux</surname><given-names>P.D.</given-names></name>
<name><surname>Levine</surname><given-names>J.M.</given-names></name>
<name><surname>Kofke</surname><given-names>W.A.</given-names></name>
</person-group><publisher-name>W.B. Saunders</publisher-name><publisher-loc>Philadelphia, PA, USA</publisher-loc><year>2013</year><fpage>107</fpage><lpage>113.e2</lpage><isbn>978-1-4377-0167-8</isbn></element-citation></ref><ref id="B22-jfmk-10-00161"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hern&#x000e1;ndez</surname><given-names>E.D.</given-names></name>
<name><surname>Forero</surname><given-names>S.M.</given-names></name>
<name><surname>Galeano</surname><given-names>C.P.</given-names></name>
<name><surname>Barbosa</surname><given-names>N.E.</given-names></name>
<name><surname>Sunnerhagen</surname><given-names>K.S.</given-names></name>
<name><surname>Alt Murphy</surname><given-names>M.</given-names></name>
</person-group><article-title>Intra- and Inter-Rater Reliability of Fugl-Meyer Assessment of Lower Extremity Early after Stroke</article-title><source>Braz. J. Phys. Ther.</source><year>2021</year><volume>25</volume><fpage>709</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.bjpt.2020.12.002</pub-id><pub-id pub-id-type="pmid">33358073</pub-id>
</element-citation></ref><ref id="B23-jfmk-10-00161"><label>23.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>G-EO1 (n.d.)</collab>
</person-group><article-title>Reha Technology</article-title><comment>Available online: <ext-link xlink:href="https://www.rehatechnology.com/en/g-eo1/" ext-link-type="uri">https://www.rehatechnology.com/en/g-eo1/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-02-11">(accessed on 11 February 2025)</date-in-citation></element-citation></ref><ref id="B24-jfmk-10-00161"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>McCulloch</surname><given-names>C.E.</given-names></name>
<name><surname>Searle</surname><given-names>S.R.</given-names></name>
</person-group><source>Generalized, Linear, and Mixed Models</source><edition>1st ed.</edition><series>Wiley Series in Probability and Statistics</series><publisher-name>Wiley</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2000</year><isbn>978-0-471-19364-7</isbn></element-citation></ref><ref id="B25-jfmk-10-00161"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balasubramanian</surname><given-names>C.K.</given-names></name>
<name><surname>Bowden</surname><given-names>M.G.</given-names></name>
<name><surname>Neptune</surname><given-names>R.R.</given-names></name>
<name><surname>Kautz</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Relationship Between Step Length Asymmetry and Walking Performance in Subjects With Chronic Hemiparesis</article-title><source>Arch. Phys. Med. Rehabil.</source><year>2007</year><volume>88</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2006.10.004</pub-id><pub-id pub-id-type="pmid">17207674</pub-id>
</element-citation></ref><ref id="B26-jfmk-10-00161"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patterson</surname><given-names>K.K.</given-names></name>
<name><surname>Gage</surname><given-names>W.H.</given-names></name>
<name><surname>Brooks</surname><given-names>D.</given-names></name>
<name><surname>Black</surname><given-names>S.E.</given-names></name>
<name><surname>McIlroy</surname><given-names>W.E.</given-names></name>
</person-group><article-title>Changes in Gait Symmetry and Velocity After Stroke: A Cross-Sectional Study From Weeks to Years After Stroke</article-title><source>Neurorehabil. Neural Repair.</source><year>2010</year><volume>24</volume><fpage>783</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1177/1545968310372091</pub-id><pub-id pub-id-type="pmid">20841442</pub-id>
</element-citation></ref><ref id="B27-jfmk-10-00161"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ada</surname><given-names>L.</given-names></name>
<name><surname>Dean</surname><given-names>C.M.</given-names></name>
<name><surname>Lindley</surname><given-names>R.</given-names></name>
<name><surname>Lloyd</surname><given-names>G.</given-names></name>
</person-group><article-title>Improving Community Ambulation after Stroke: The AMBULATE Trial</article-title><source>BMC Neurol.</source><year>2009</year><volume>9</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2377-9-8</pub-id><pub-id pub-id-type="pmid">19208261</pub-id>
</element-citation></ref><ref id="B28-jfmk-10-00161"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Benjamini</surname><given-names>Y.</given-names></name>
<name><surname>Hochberg</surname><given-names>Y.</given-names></name>
</person-group><article-title>Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing</article-title><source>J. R. Stat. Soc. Ser. B Stat. Methodol.</source><year>1995</year><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></element-citation></ref><ref id="B29-jfmk-10-00161"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
<name><surname>Naro</surname><given-names>A.</given-names></name>
<name><surname>Russo</surname><given-names>M.</given-names></name>
<name><surname>Bramanti</surname><given-names>P.</given-names></name>
<name><surname>Carioti</surname><given-names>L.</given-names></name>
<name><surname>Balletta</surname><given-names>T.</given-names></name>
<name><surname>Buda</surname><given-names>A.</given-names></name>
<name><surname>Manuli</surname><given-names>A.</given-names></name>
<name><surname>Filoni</surname><given-names>S.</given-names></name>
<name><surname>Bramanti</surname><given-names>A.</given-names></name>
</person-group><article-title>Shaping Neuroplasticity by Using Powered Exoskeletons in Patients with Stroke: A Randomized Clinical Trial</article-title><source>J. Neuroeng. Rehabil.</source><year>2018</year><volume>15</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/s12984-018-0377-8</pub-id><pub-id pub-id-type="pmid">29695280</pub-id>
</element-citation></ref><ref id="B30-jfmk-10-00161"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Androwis</surname><given-names>G.J.</given-names></name>
<name><surname>Pilkar</surname><given-names>R.</given-names></name>
<name><surname>Ramanujam</surname><given-names>A.</given-names></name>
<name><surname>Nolan</surname><given-names>K.J.</given-names></name>
</person-group><article-title>Electromyography Assessment During Gait in a Robotic Exoskeleton for Acute Stroke</article-title><source>Front. Neurol.</source><year>2018</year><volume>9</volume><elocation-id>630</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2018.00630</pub-id><pub-id pub-id-type="pmid">30131756</pub-id>
</element-citation></ref><ref id="B31-jfmk-10-00161"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.</given-names></name>
<name><surname>Park</surname><given-names>G.</given-names></name>
<name><surname>Shin</surname><given-names>J.-H.</given-names></name>
<name><surname>You</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Neuroplastic Effects of End-Effector Robotic Gait Training for Hemiparetic Stroke: A Randomised Controlled Trial</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>12461</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-69367-3</pub-id><pub-id pub-id-type="pmid">32719420</pub-id>
</element-citation></ref><ref id="B32-jfmk-10-00161"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darak</surname><given-names>V.</given-names></name>
<name><surname>Karthikbabu</surname><given-names>S.</given-names></name>
</person-group><article-title>Lower Limb Motor Function and Hip Muscle Weakness in Stroke Survivors and Their Relationship with Pelvic Tilt, Weight-Bearing Asymmetry, and Gait Speed: A Cross-Sectional Study</article-title><source>Curr. J. Neurol.</source><year>2020</year><volume>19</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.18502/ijnl.v19i1.3275</pub-id></element-citation></ref><ref id="B33-jfmk-10-00161"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tyson</surname><given-names>S.F.</given-names></name>
<name><surname>Crow</surname><given-names>J.L.</given-names></name>
<name><surname>Connell</surname><given-names>L.</given-names></name>
<name><surname>Winward</surname><given-names>C.</given-names></name>
<name><surname>Hillier</surname><given-names>S.</given-names></name>
</person-group><article-title>Sensory Impairments of the Lower Limb after Stroke: A Pooled Analysis of Individual Patient Data</article-title><source>Top. Stroke Rehabil.</source><year>2013</year><volume>20</volume><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1310/tsr2005-441</pub-id><pub-id pub-id-type="pmid">24091286</pub-id>
</element-citation></ref><ref id="B34-jfmk-10-00161"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maier</surname><given-names>M.</given-names></name>
<name><surname>Ballester</surname><given-names>B.R.</given-names></name>
<name><surname>Verschure</surname><given-names>P.F.M.J.</given-names></name>
</person-group><article-title>Principles of Neurorehabilitation After Stroke Based on Motor Learning and Brain Plasticity Mechanisms</article-title><source>Front. Syst. Neurosci.</source><year>2019</year><volume>13</volume><elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2019.00074</pub-id><pub-id pub-id-type="pmid">31920570</pub-id>
</element-citation></ref><ref id="B35-jfmk-10-00161"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonanno</surname><given-names>M.</given-names></name>
<name><surname>Maggio</surname><given-names>M.G.</given-names></name>
<name><surname>Ciatto</surname><given-names>L.</given-names></name>
<name><surname>De Luca</surname><given-names>R.</given-names></name>
<name><surname>Quartarone</surname><given-names>A.</given-names></name>
<name><surname>Alibrandi</surname><given-names>A.</given-names></name>
<name><surname>Calabr&#x000f2;</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Can Robotic Gait Training with End Effectors Improve Lower-Limb Functions in Patients Affected by Multiple Sclerosis? Results from a Retrospective Case&#x02013;Control Study</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>1545</elocation-id><pub-id pub-id-type="doi">10.3390/jcm13061545</pub-id><pub-id pub-id-type="pmid">38541771</pub-id>
</element-citation></ref><ref id="B36-jfmk-10-00161"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mao</surname><given-names>Y.-R.</given-names></name>
<name><surname>Lo</surname><given-names>W.L.</given-names></name>
<name><surname>Lin</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Xiao</surname><given-names>X.</given-names></name>
<name><surname>Raghavan</surname><given-names>P.</given-names></name>
<name><surname>Huang</surname><given-names>D.-F.</given-names></name>
</person-group><article-title>The Effect of Body Weight Support Treadmill Training on Gait Recovery, Proximal Lower Limb Motor Pattern, and Balance in Patients with Subacute Stroke</article-title><source>Biomed. Res. Int.</source><year>2015</year><volume>2015</volume><elocation-id>175719</elocation-id><pub-id pub-id-type="doi">10.1155/2015/175719</pub-id><pub-id pub-id-type="pmid">26649295</pub-id>
</element-citation></ref><ref id="B37-jfmk-10-00161"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dayan</surname><given-names>E.</given-names></name>
<name><surname>Cohen</surname><given-names>L.G.</given-names></name>
</person-group><article-title>Neuroplasticity Subserving Motor Skill Learning</article-title><source>Neuron</source><year>2011</year><volume>72</volume><fpage>443</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.10.008</pub-id><pub-id pub-id-type="pmid">22078504</pub-id>
</element-citation></ref><ref id="B38-jfmk-10-00161"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banyai</surname><given-names>A.D.</given-names></name>
<name><surname>Bri&#x00219;an</surname><given-names>C.</given-names></name>
</person-group><article-title>Robotics in Physical Rehabilitation: Systematic Review</article-title><source>Healthcare</source><year>2024</year><volume>12</volume><elocation-id>1720</elocation-id><pub-id pub-id-type="doi">10.3390/healthcare12171720</pub-id><pub-id pub-id-type="pmid">39273744</pub-id>
</element-citation></ref><ref id="B39-jfmk-10-00161"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kugler</surname><given-names>C.</given-names></name>
<name><surname>Altenh&#x000f6;ner</surname><given-names>T.</given-names></name>
<name><surname>Lochner</surname><given-names>P.</given-names></name>
<name><surname>Ferbert</surname><given-names>A.</given-names></name>
</person-group><article-title>Hessian Stroke Data Bank Study Group ASH Does Age Influence Early Recovery from Ischemic Stroke? A Study from the Hessian Stroke Data Bank</article-title><source>J. Neurol.</source><year>2003</year><volume>250</volume><fpage>676</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1007/s00415-003-1054-8</pub-id><pub-id pub-id-type="pmid">12796828</pub-id>
</element-citation></ref><ref id="B40-jfmk-10-00161"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoo</surname><given-names>J.W.</given-names></name>
<name><surname>Hong</surname><given-names>B.Y.</given-names></name>
<name><surname>Jo</surname><given-names>L.</given-names></name>
<name><surname>Kim</surname><given-names>J.-S.</given-names></name>
<name><surname>Park</surname><given-names>J.G.</given-names></name>
<name><surname>Shin</surname><given-names>B.K.</given-names></name>
<name><surname>Lim</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Effects of Age on Long-Term Functional Recovery in Patients with Stroke</article-title><source>Medicina</source><year>2020</year><volume>56</volume><elocation-id>451</elocation-id><pub-id pub-id-type="doi">10.3390/medicina56090451</pub-id><pub-id pub-id-type="pmid">32906615</pub-id>
</element-citation></ref><ref id="B41-jfmk-10-00161"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tomida</surname><given-names>K.</given-names></name>
<name><surname>Ohtsuka</surname><given-names>K.</given-names></name>
<name><surname>Teranishi</surname><given-names>T.</given-names></name>
<name><surname>Ogawa</surname><given-names>H.</given-names></name>
<name><surname>Takai</surname><given-names>M.</given-names></name>
<name><surname>Suzuki</surname><given-names>A.</given-names></name>
<name><surname>Kawakami</surname><given-names>K.</given-names></name>
<name><surname>Sonoda</surname><given-names>S.</given-names></name>
</person-group><article-title>Effects of Change in Walking Speed on Time-Distance Parameters in Post-Stroke Hemiplegic Gait</article-title><source>Fujita Med. J.</source><year>2022</year><volume>8</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.20407/fmj.2021-016</pub-id><pub-id pub-id-type="pmid">36415831</pub-id>
</element-citation></ref><ref id="B42-jfmk-10-00161"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fukuchi</surname><given-names>C.A.</given-names></name>
<name><surname>Fukuchi</surname><given-names>R.K.</given-names></name>
<name><surname>Duarte</surname><given-names>M.</given-names></name>
</person-group><article-title>Effects of Walking Speed on Gait Biomechanics in Healthy Participants: A Systematic Review and Meta-Analysis</article-title><source>Syst. Rev.</source><year>2019</year><volume>8</volume><fpage>153</fpage><pub-id pub-id-type="doi">10.1186/s13643-019-1063-z</pub-id><pub-id pub-id-type="pmid">31248456</pub-id>
</element-citation></ref><ref id="B43-jfmk-10-00161"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hesse</surname><given-names>S.</given-names></name>
<name><surname>Waldner</surname><given-names>A.</given-names></name>
<name><surname>Tomelleri</surname><given-names>C.</given-names></name>
</person-group><article-title>Innovative Gait Robot for the Repetitive Practice of Floor Walking and Stair Climbing up and down in Stroke Patients</article-title><source>J. Neuroeng. Rehabil.</source><year>2010</year><volume>7</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1186/1743-0003-7-30</pub-id><pub-id pub-id-type="pmid">20584307</pub-id>
</element-citation></ref><ref id="B44-jfmk-10-00161"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nascimento</surname><given-names>L.R.</given-names></name>
<name><surname>de Oliveira</surname><given-names>C.Q.</given-names></name>
<name><surname>Ada</surname><given-names>L.</given-names></name>
<name><surname>Michaelsen</surname><given-names>S.M.</given-names></name>
<name><surname>Teixeira-Salmela</surname><given-names>L.F.</given-names></name>
</person-group><article-title>Walking Training with Cueing of Cadence Improves Walking Speed and Stride Length after Stroke More than Walking Training Alone: A Systematic Review</article-title><source>J. Physiother.</source><year>2015</year><volume>61</volume><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jphys.2014.11.015</pub-id><pub-id pub-id-type="pmid">25529836</pub-id>
</element-citation></ref><ref id="B45-jfmk-10-00161"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goffredo</surname><given-names>M.</given-names></name>
<name><surname>Iacovelli</surname><given-names>C.</given-names></name>
<name><surname>Russo</surname><given-names>E.</given-names></name>
<name><surname>Pournajaf</surname><given-names>S.</given-names></name>
<name><surname>Di Blasi</surname><given-names>C.</given-names></name>
<name><surname>Galafate</surname><given-names>D.</given-names></name>
<name><surname>Pellicciari</surname><given-names>L.</given-names></name>
<name><surname>Agosti</surname><given-names>M.</given-names></name>
<name><surname>Filoni</surname><given-names>S.</given-names></name>
<name><surname>Aprile</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Stroke Gait Rehabilitation: A Comparison of End-Effector, Overground Exoskeleton, and Conventional Gait Training</article-title><source>Appl. Sci.</source><year>2019</year><volume>9</volume><elocation-id>2627</elocation-id><pub-id pub-id-type="doi">10.3390/app9132627</pub-id></element-citation></ref><ref id="B46-jfmk-10-00161"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hollman</surname><given-names>J.H.</given-names></name>
<name><surname>McDade</surname><given-names>E.M.</given-names></name>
<name><surname>Petersen</surname><given-names>R.C.</given-names></name>
</person-group><article-title>Normative Spatiotemporal Gait Parameters in Older Adults</article-title><source>Gait Posture</source><year>2011</year><volume>34</volume><fpage>111</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.gaitpost.2011.03.024</pub-id><pub-id pub-id-type="pmid">21531139</pub-id>
</element-citation></ref><ref id="B47-jfmk-10-00161"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ardestani</surname><given-names>M.M.</given-names></name>
<name><surname>Ferrigno</surname><given-names>C.</given-names></name>
<name><surname>Moazen</surname><given-names>M.</given-names></name>
<name><surname>Wimmer</surname><given-names>M.A.</given-names></name>
</person-group><article-title>From Normal to Fast Walking: Impact of Cadence and Stride Length on Lower Extremity Joint Moments</article-title><source>Gait Posture</source><year>2016</year><volume>46</volume><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.gaitpost.2016.02.005</pub-id><pub-id pub-id-type="pmid">27131188</pub-id>
</element-citation></ref><ref id="B48-jfmk-10-00161"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eng</surname><given-names>J.J.</given-names></name>
<name><surname>Tang</surname><given-names>P.F.</given-names></name>
</person-group><article-title>Gait Training Strategies to Optimize Walking Ability in People with Stroke: A Synthesis of the Evidence</article-title><source>Expert. Rev. Neurother.</source><year>2007</year><volume>7</volume><fpage>1417</fpage><lpage>1436</lpage><pub-id pub-id-type="doi">10.1586/14737175.7.10.1417</pub-id><pub-id pub-id-type="pmid">17939776</pub-id>
</element-citation></ref><ref id="B49-jfmk-10-00161"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teodoro</surname><given-names>J.</given-names></name>
<name><surname>Fernandes</surname><given-names>S.</given-names></name>
<name><surname>Castro</surname><given-names>C.</given-names></name>
<name><surname>Fernandes</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Current Trends in Gait Rehabilitation for Stroke Survivors: A Scoping Review of Randomized Controlled Trials</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>1358</elocation-id><pub-id pub-id-type="doi">10.3390/jcm13051358</pub-id><pub-id pub-id-type="pmid">38592172</pub-id>
</element-citation></ref><ref id="B50-jfmk-10-00161"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Katz</surname><given-names>R.T.</given-names></name>
<name><surname>Rymer</surname><given-names>W.Z.</given-names></name>
</person-group><article-title>Spastic Hypertonia: Mechanisms and Measurement</article-title><source>Arch. Phys. Med. Rehabil.</source><year>1989</year><volume>70</volume><fpage>144</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">2644919</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="jfmk-10-00161-f001"><label>Figure 1</label><caption><p>Post-stroke patient performing gait training on the G-EO system. The figure shows a patient performing an RGT session on the G-EO system. The monitor in front of the patient, as well as the second monitor of the therapist, provides visual real-time feedback on the patient&#x02019;s performance, including footplate pressure feedback, active therapy duration, repetitions, and distance covered.</p></caption><graphic xlink:href="jfmk-10-00161-g001" position="float"/></fig><fig position="float" id="jfmk-10-00161-f002"><label>Figure 2</label><caption><p>Fugl-Meyer Assessment&#x02014;Lower extremity (FMA-LE) scores evaluated before and after RGT in the EG. The figure shows boxplots for each item of FMA-LE comparing before (T0&#x02014;light blue) and after (T1&#x02014;dark blue) RGT. Item E = lower extremity; Item F = coordination/speed; Item total E-F = motor function; Item H = sensation; Item JI = passive joint motion; Item JII = joint pain. The outliers are plotted using the + marker symbol.</p></caption><graphic xlink:href="jfmk-10-00161-g002" position="float"/></fig><fig position="float" id="jfmk-10-00161-f003"><label>Figure 3</label><caption><p>Tinetti Scale (TS) evaluating balance and gait functions. The left panel shows the TS balance boxplot comparing before (T0) and after (T1) RGT (green) and CGT (orange). The right panel shows the TS gait boxplot comparing before (T0) and after (T1) RGT (green) and CGT (orange). The outliers are plotted using the + marker symbol.</p></caption><graphic xlink:href="jfmk-10-00161-g003" position="float"/></fig><table-wrap position="float" id="jfmk-10-00161-t001"><object-id pub-id-type="pii">jfmk-10-00161-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic and clinical characteristics of both groups (experimental&#x02014;RGT and control&#x02014;conventional rehabilitation training).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Characteristic
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
All
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
EG
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
CG
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>
-Value
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Test
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Patients</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (100%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (50%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (50%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">51.13 &#x000b1; 13.72</td><td align="center" valign="middle" rowspan="1" colspan="1">47 &#x000b1; 12.54</td><td align="center" valign="middle" rowspan="1" colspan="1">55.25 &#x000b1; 14.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Education (years)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.92 &#x000b1; 2.96</td><td align="center" valign="middle" rowspan="1" colspan="1">12.92 &#x000b1; 2.64</td><td align="center" valign="middle" rowspan="1" colspan="1">12.92 &#x000b1; 3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">U</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Male</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (66.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (66.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (66.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fisher</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Female</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (33.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (33.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (33.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fisher</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Time since injury (years)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.25 &#x000b1; 1.62</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33 &#x000b1; 1.78</td><td align="center" valign="middle" rowspan="1" colspan="1">2.17 &#x000b1; 1.53</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">U</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Etiology</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Ischemic</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (54.17%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (58.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (50%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c7;<sup>2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Hemorrhagic</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (45.83%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (41.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (50%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c7;<sup>2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Most affected side</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Left</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (45.83%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (41.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (50%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c7;<sup>2</sup></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Right</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (54.17%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (58.33%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (50%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003c7;<sup>2</sup></td></tr></tbody></table><table-wrap-foot><fn><p><bold>Legend:</bold> Fisher (Fisher&#x02019;s exact test); &#x003c7;<sup>2</sup> (chi-squared test); U (Mann&#x02013;Whitney U test).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jfmk-10-00161-t002"><object-id pub-id-type="pii">jfmk-10-00161-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of the characteristics linked to RGT and CGT protocols.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Rehabilitation Intervention Elements</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CGT</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RGT</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Setting</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conventional physiotherapy gym </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G-EO system robotic device</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Duration of gait training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 h </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gait training </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#x02032; postural alignment with the aid of the physiotherapist<break/>20&#x02032; gait training exercises: walking over obstacles of different sizes, tandem and slalom walking<break/>10&#x02032; weight-shifting, core muscle strengthening, monopodal and bipodal balance exercises,<break/>10&#x02032; ascending and descending stairs <break/>10&#x02032; cool down and return to sitting position</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#x02032; postural alignment with G-EO system<break/>30&#x02032; gait training on the G-EO system, focusing on proper weight distribution between the two legs<break/>10&#x02032; ascending and descending stairs with G-EO<break/>10&#x02032; cool down and return to sitting position</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascending and descending stairs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes<break/>With the supervision and manual guidance of the physiotherapist </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes<break/>With the supervision of the physiotherapist and the guidance provided by the robotic device </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guidance </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Manual guidance provided by the physiotherapist</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BWS and robotic guidance&#x02014;when needed, the physiotherapist provided supervision and/or hands-on support to the paretic knee of the patients </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Audio&#x02013;visual Feedback</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verbal feedback provided by the physiotherapist</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Visual feedback provided by the monitor of the G-EO system and verbal feedback provided by the physiotherapist, as needed</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatigue management </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes<break/>Visible signs of fatigue (e.g., changes in gait quality or shortness of breath)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes <break/>Visible signs of fatigue (e.g., changes in gait quality or shortness of breath)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rehabilitation parameters</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes <break/>Step cadence and velocity</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conventional physiotherapy </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes<break/>45&#x02032; of stretching exercises, passive and active-assisted limb mobilization, and therapeutic exercises </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes <break/>45&#x02032; of stretching exercises, passive and active-assisted limb mobilization, and therapeutic exercises </td></tr></tbody></table></table-wrap><table-wrap position="float" id="jfmk-10-00161-t003"><object-id pub-id-type="pii">jfmk-10-00161-t003_Table 3</object-id><label>Table 3</label><caption><p>Statistical comparisons (<italic toggle="yes">p</italic>-values) between T0 and T1 for each group and between EG and CG at T0 and T1 (EG vs. CT).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Scale/Test</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EG<break/>T0&#x02013;T1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CG<break/>T0&#x02013;T1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EG vs. CG<break/>T0&#x02013;T0</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EG vs. CG<break/>&#x00394; (T1&#x02013;T0)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>10MWT</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.014</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.295</td><td align="center" valign="middle" rowspan="1" colspan="1">0.255</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Tinetti&#x02013;Balance</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.012</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.277</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Tinetti&#x02013;Gait</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.05</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>MAS</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">0.453</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.342</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>FIM</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.977</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.183</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Legend:</bold> 10WMT (10 m Walking Test), MAS (Modified Ashworth Scale), FIM (Functional Independence Measure); &#x00394; (T1&#x02013;T0): difference of &#x0201c;after treatment&#x02013;before treatment&#x0201d;. Significant <italic toggle="yes">p</italic>-values are reported in bold.</p></fn></table-wrap-foot></table-wrap></floats-group></article>